Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes

Journal of Biological Chemistry

Volumn 290, Issue 5, 2015, Pages 3121-3136

  Raval, Kunil K ^a,b   Tao, Ran ^a   White, Brent E ^a   De Lange, Willem J ^c   Koonce, Chad H ^a   Yu, Junying ^d   Kishnani, Priya S ^f   Thomson, James A ^a,e   Mosher, Deane F ^a,c   Ralphe, John C ^c   Kamp, Timothy J ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b WiCell Institute   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d Cellular Dynamics International   (United States)

^e MORGRIDGE INSTITUTE FOR RESEARCH   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MEMBRANES; CELL CULTURE; ELECTROPHORESIS; ELECTROPHORETIC MOBILITY; GALLIUM ALLOYS; GLYCOSYLATION; LIGHTING; MUSCLE; PEDIATRICS; PLANTS (BOTANY); POLYSACCHARIDES; PROTEINS; STEM CELLS;

CONGENITAL DISORDERS; HUMAN-INDUCED PLURIPOTENT STEM CELLS; HYDROLYZING ENZYMES; HYPERTROPHIC CARDIOMYOPATHY; ISOELECTRIC FOCUSING; MALDI-TOF-MS ANALYSIS; MEMBRANE PROTEINS; RECESSIVE DISORDER;

ESTERIFICATION;

ALPHA GLUCOSIDASE; GLYCAN;

ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; BINDING AFFINITY; CARBOHYDRATE SYNTHESIS; CARDIOMYOPATHY; CELL DIFFERENTIATION; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; FIBROBLAST; GLYCOGEN STORAGE DISEASE TYPE 2; GOLGI COMPLEX; HEART CONTRACTION; HEART MUSCLE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROLYSIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEAR REPROGRAMMING; PATHOGENESIS; PLURIPOTENT STEM CELL; PROTEIN GLYCOSYLATION; SIALYLATION; SKELETAL MUSCLE; CELL CULTURE; CYTOLOGY; GENOTYPE; GLYCOSYLATION; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; WESTERN BLOTTING;

IPS;

BLOTTING, WESTERN; CELLS, CULTURED; GENOTYPE; GLYCOGEN STORAGE DISEASE TYPE II; GLYCOSYLATION; GOLGI APPARATUS; HUMANS; IMMUNOHISTOCHEMISTRY; INDUCED PLURIPOTENT STEM CELLS; MYOCYTES, CARDIAC;

EID: 84921926095     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.628628     Document Type: Article

References (88)

1. van der Ploeg, A. T., and Reuser, A. J. (2008) Pompe's disease. Lancet 372, 1342-1353
2. Kishnani, P. S., Hwu, W. L., Mandel, H., Nicolino, M., Yong, F., Corzo, D., and Infantile-Onset Pompe Disease Natural History Study Group (2006) A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J. Pediatr. 148, 671-676
3. Kishnani, P. S., Goldenberg, P. C., DeArmey, S. L., Heller, J., Benjamin, D., Young, S., Bali, D., Smith, S. A., Li, J. S., Mandel, H., Koeberl, D., Rosenberg, A., and Chen, Y. T. (2010) Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants. Mol. Genet. Metab. 99, 26-33
4. Shea, L., and Raben, N. (2009) Autophagy in skeletal muscle: implications for Pompe disease. Int. J. Clin. Pharmacol. Ther. 47, Suppl. 1, S42-S47
5. Chen, L. R., Chen, C. A., Chiu, S. N., Chien, Y. H., Lee, N. C., Lin, M. T., Hwu, W. L., Wang, J. K., and Wu, M. H. (2009) Reversal of cardiac dysfunction after enzyme replacement in patients with infantile-onset Pompe disease. J. Pediatr. 155, 271-275
6. McDowell, R., Li, J. S., Benjamin, D. K., Jr., Morgan, C., Becker, A., Kishnani, P. S., and Kanter, R. J. (2008) Arrhythmias in patients receiving enzyme replacement therapy for infantile Pompe disease. Genet. Med. 10, 758-762
7. Thurberg, B. L., Lynch Maloney, C., Vaccaro, C., Afonso, K., Tsai, A. C., Bossen, E., Kishnani, P. S., and O'Callaghan, M. (2006) Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease. Lab. Invest. 86, 1208-1220
8. Xu, S., Galperin, M., Melvin, G., Horowits, R., Raben, N., Plotz, P., and Yu, L. (2010) Impaired organization and function of myofilaments in single muscle fibers from a mouse model of Pompe disease. J. Appl. Physiol. 108, 1383-1388
9. Nascimbeni, A. C., Fanin, M., Masiero, E., Angelini, C., and Sandri, M. (2012) The role of autophagy in the pathogenesis of glycogen storage disease type II (GSDII). Cell Death Differ. 19, 1698-1708
10. Raben, N., Ralston, E., Chien, Y. H., Baum, R., Schreiner, C., Hwu, W. L., Zaal, K. J., and Plotz, P. H. (2010) Differences in the predominance of lysosomal and autophagic pathologies between infants and adults with Pompe disease: implications for therapy. Mol. Genet. Metab. 101, 324-331
11. Raben, N., Hill, V., Shea, L., Takikita, S., Baum, R., Mizushima, N., Ralston, E., and Plotz, P. (2008) Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease. Hum. Mol. Genet. 17, 3897-3908
12. Takikita, S., Myerowitz, R., Zaal, K., Raben, N., and Plotz, P. H. (2009) Murine muscle cell models for Pompe disease and their use in studying therapeutic approaches. Mol. Genet. Metab. 96, 208-217
13. Raben, N., Wong, A., Ralston, E., and Myerowitz, R. (2012) Autophagy and mitochondria in Pompe disease: nothing is so new as what has long been forgotten. Am. J. Med. Genet. C Semin. Med. Genet. 160, 13-21
14. Lieberman, A. P., Puertollano, R., Raben, N., Slaugenhaupt, S., Walkley, S. U., and Ballabio, A. (2012) Autophagy in lysosomal storage disorders. Autophagy 8, 719-730
15. Moore, J. R., Leinwand, L., and Warshaw, D. M. (2012) Understanding cardiomyopathy phenotypes based on the functional impact of mutations in the myosin motor. Circ. Res. 111, 375-385
16. De Lange, W. J., Grimes, A. C., Hegge, L. F., Spring, A. M., Brost, T. M., and Ralphe, J. C. (2013) E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction. J. Gen. Physiol. 142, 241-255
17. Footitt, E. J., Karimova, A., Burch, M., Yayeh, T., Dupre, T., et al. (2009) Cardiomyopathy in the congenital disorders of glycosylation (CDG): a case of late presentation and literature review. J. Inherit. Metab. Dis. 32, Suppl. 1, S313-S319
18. Maron, B. J., Roberts, W. C., Arad, M., Haas, T. S., Spirito, P., Wright, G. B., Almquist, A. K., Baffa, J. M., Saul, J. P., Ho, C. Y., Seidman, J., and Seidman, C. E. (2009) Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy. JAMA 301, 1253-1259
19. Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., and Thomson, J. A. (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science 324, 797-801
20. Ludwig, T. E., Levenstein, M. E., Jones, J. M., Berggren, W. T., Mitchen, E. R., Frane, J.L., Crandall, L. J., Daigh, C. A., Conard, K. R., Piekarczyk, M. S., Llanas, R. A., and Thomson, J. A. (2006) Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol. 24, 185-187
21. Reuser, A. J., Koster, J. F., Hoogeveen, A., and Galjaard, H. (1978) Biochemical, immunological, and cell genetic studies in glycogenosis type II. Am. J. Hum. Genet. 30, 132-143
22. Lian, X., Hsiao, C., Wilson, G., Zhu, K., Hazeltine, L. B., Azarin, S. M., Raval, K. K., Zhang, J., Kamp, T. J., and Palecek, S. P. (2012) Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc. Natl. Acad. Sci. U.S.A. 109, E1848-E1857
23. Schaaf, S., Shibamiya, A., Mewe, M., Eder, A., Stöhr, A., Hirt, M. N., Rau, T., Zimmermann, W. H., Conradi, L., Eschenhagen, T., and Hansen, A. (2011) Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PLoS One 6, e26397
24. Hansen, A., Eder, A., Bönstrup, M., Flato, M., Mewe, M., Schaaf, S., Aksehirlioglu, B., Schwoerer, A. P., Schwörer, A., Uebeler, J., and Eschenhagen, T. (2010) Development of a drug screening platform based on engineered heart tissue. Circ. Res. 107, 35-44
25. de Lange, W. J., Hegge, L. F., Grimes, A. C., Tong, C. W., Brost, T. M., Moss, R. L., and Ralphe, J. C. (2011) Neonatal mouse-derived engineered cardiac tissue: a novel model system for studying genetic heart disease. Circ. Res. 109, 8-19
26. Wessel, D., and Flügge, U. I. (1984)Amethod for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem. 138, 141-143
27. Michele, D. E., Barresi, R., Kanagawa, M., Saito, F., Cohn, R. D., Satz, J. S., Dollar, J., Nishino, I., Kelley, R. I., Somer, H., Straub, V., Mathews, K. D., Moore, S. A., and Campbell, K. P. (2002) Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418, 417-422
28. O'Farrell, P. H. (1975) High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250, 4007-4021
29. Burgess-Cassler, A., Johansen, J. J., Santek, D. A., Ide, J. R., and Kendrick, N. C. (1989) Computerized quantitative analysis of Coomassie-blue-stained serum proteins separated by two-dimensional electrophoresis. Clin. Chem. 35, 2297-2304
30. Anumula, K. R., and Taylor, P. B. (1992) A comprehensive procedure for preparation of partially methylated alditol acetates from glycoprotein carbohydrates. Anal. Biochem. 203, 101-108
31. Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., Slukvin, I. I., and Thomson, J. A. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920
32. Moreland, R. J., Jin, X., Zhang, X. K., Decker, R. W., Albee, K. L., Lee, K. L., Cauthron, R. D., Brewer, K., Edmunds, T., and Canfield, W.M. (2005) Lysosomal acid α-glucosidase consists of four different peptides processed from a single chain precursor. J. Biol. Chem. 280, 6780-6791
33. Ausems, M. G., Kroos, M. A., Van der Kraan, M., Smeitink, J. A., Kleijer, W. J., Ploos van Amstel, H. K., and Reuser, A. J. (1996) Homozygous deletion of exon 18 leads to degradation of the lysosomal α-glucosidase precursor and to the infantile form of glycogen storage disease type II. Clin. Genet. 49, 325-328
34. Lynch, C. M., Johnson, J., Vaccaro, C., and Thurberg, B. L. (2005) High-resolution light microscopy (HRLM) and digital analysis of Pompe disease pathology. J. Histochem. Cytochem. 53, 63-73
35. Knaapen, M. W., Vrolijk, B. C., and Wenink, A. C. (1997) Ultrastructural changes of the myocardium in the embryonic rat heart. Anat. Rec. 248, 233-241
36. Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., Ahn, H. J., Ait-Mohamed, O., Ait-Si-Ali, S., Akematsu, T., Akira, S., et al. (2012) Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8, 445-544
37. Meikle, P. J., Brooks, D. A., Ravenscroft, E. M., Yan, M., Williams, R. E., Jaunzems, A. E., Chataway, T. K., Karageorgos, L. E., Davey, R. C., Boulter, C. D., Carlsson, S. R., and Hopwood, J. J. (1997) Diagnosis of lysosomal storage disorders: evaluation of lysosome-associated membrane protein LAMP-1 as a diagnostic marker. Clin. Chem. 43, 1325-1335
38. Carlsson, S. R., Roth, J., Piller, F., and Fukuda, M. (1988) Isolation and characterization of human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2: major sialoglycoproteins carrying polylactosaminoglycan. J. Biol. Chem. 263, 18911-18919
39. Carlsson, S. R., Lycksell, P. O., and Fukuda, M. (1993) Assignment of O-glycan attachment sites to the hinge-like regions of human lysosomal membrane glycoproteins lamp-1 and lamp-2. Arch. Biochem. Biophys. 304, 65-73
40. Nabi, I. R., and Dennis, J. W. (1998) The extent of polylactosamine glycosylation of MDCK LAMP-2 is determined by its Golgi residence time. Glycobiology 8, 947-953
41. Carlsson, S. R., and Fukuda, M. (1990) The polylactosaminoglycans of human lysosomal membrane glycoproteins lamp-1 and lamp-2: localization on the peptide backbones. J. Biol. Chem. 265, 20488-20495
42. Fujiwara, T., Oda, K., Yokota, S., Takatsuki, A., and Ikehara, Y. (1988) Brefeldin A causes disassembly of the Golgi complex and accumulation of secretory proteins in the endoplasmic reticulum. J. Biol. Chem. 263, 18545-18552
43. Isaac, E. L., Karageorgos, L. E., Brooks, D. A., Hopwood, J. J., and Meikle, P. J. (2000) Regulation of the lysosome-associated membrane protein in a sucrose model of lysosomal storage. Exp. Cell Res. 254, 204-209
44. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., and Walker, P. (2002) Transport from the ER through the Golgi apparatus. in Molecular Biology of the Cell, 4th Ed., Garland Science, New York, http://www.ncbi.nlm.nih.gov/books/NBK26941/
45. Chen, J. W., Pan, W., D'Souza, M. P., and August, J. T. (1985) Lysosome-associated membrane proteins: characterization of LAMP-1 of macrophage P388 and mouse embryo 3T3 cultured cells. Arch. Biochem. Biophys. 239, 574-586
46. Chui, D., Oh-Eda, M., Liao, Y. F., Panneerselvam, K., Lal, A., Marek, K. W., Freeze, H. H., Moremen, K. W., Fukuda, M. N., and Marth, J. D. (1997) α-Mannosidase-II deficiency results in dyserythropoiesis and unveils an alternate pathway in oligosaccharide biosynthesis. Cell 90, 157-167
47. Brockington, M., Torelli, S., Prandini, P., Boito, C., Dolatshad, N. F., Longman, C., Brown, S. C., and Muntoni, F. (2005) Localization and functional analysis of the LARGE family of glycosyltransferases: significance for muscular dystrophy. Hum. Mol. Genet. 14, 657-665
48. Inamori, K., Yoshida-Moriguchi, T., Hara, Y., Anderson, M. E., Yu, L., and Campbell, K. P. (2012) Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE. Science 335, 93-96
49. Kanagawa, M., Saito, F., Kunz, S., Yoshida-Moriguchi, T., Barresi, R., Kobayashi, Y. M., Muschler, J., Dumanski, J. P., Michele, D. E., Oldstone, M. B., and Campbell, K. P. (2004) Molecular recognition by LARGE is essential for expression of functional dystroglycan. Cell 117, 953-964
50. Sparks, S., Quijano-Roy, S., Harper, A., Rutkowski, A., Gordon, E., Hoffman, E. P., and Pegoraro, E. (1993) in GeneReviews® [Internet] (Pagon, R. A., Adam, M. P., Ardinger, H. H., et al., eds) Congenital Muscular Dystrophy Overview, University of Washington, Seattle http://www.ncbi.nlm.nih.gov/books/NBK1291
51. Ervasti, J. M., and Campbell, K. P. (1993) A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122, 809-823
52. Michele, D. E., and Campbell, K. P. (2003) Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. J. Biol. Chem. 278, 15457-15460
53. Cohen, M. W., Jacobson, C., Yurchenco, P. D., Morris, G. E., and Carbonetto, S. (1997) Laminin-induced clustering of dystroglycan on embryonic muscle cells: comparison with agrin-induced clustering. J. Cell Biol. 136, 1047-1058
54. Montanaro, F., Lindenbaum, M., and Carbonetto, S. (1999) alpha-Dystroglycan is a laminin receptor involved in extracellular matrix assembly on myotubes and muscle cell viability. J. Cell Biol. 145, 1325-1340
55. Gehrmann, J., Sohlbach, K., Linnebank, M., Böhles, H. J., Buderus, S., Kehl, H. G., Vogt, J., Harms, E., and Marquardt, T. (2003) Cardiomyopathy in congenital disorders of glycosylation. Cardiol. Young 13, 345-351
56. Kranz, C., Basinger, A. A., Gucsavas-Calikoglu, M., Sun, L., Powell, C. M., Henderson, F. W., Aylsworth, A. S., and Freeze, H. H. (2007) Expanding spectrum of congenital disorder of glycosylation Ig (CDG-Ig): sibs with a unique skeletal dysplasia, hypogammaglobulinemia, cardiomyopathy, genital malformations, and early lethality. Am. J. Med. Genet. A 143A, 1371-1378
57. Kapusta, L., Zucker, N., Frenckel, G., Medalion, B., Ben Gal, T., Birk, E., Mandel, H., Nasser, N., Morgenstern, S., Zuckermann, A., Lefeber, D. J., de Brouwer, A., Wevers, R. A., Lorber, A., and Morava, E. (2013) From discrete dilated cardiomyopathy to successful cardiac transplantation in congenital disorders of glycosylation due to dolichol kinase deficiency (DK1-CDG). Heart Fail. Rev. 18, 187-196
58. Chen, C. A., Chien, Y. H., Hwu, W. L., Lee, N. C., Wang, J. K., Chen, L. R., Lu, C. W., Lin, M. T., Chiu, S. N., Chiu, H. H., and Wu, M. H. (2011) Left ventricular geometry, global function, and dyssynchrony in infants and children with Pompe cardiomyopathy undergoing enzyme replacement therapy. J. Card. Fail. 17, 930-936
59. Raben, N., Danon, M., Gilbert, A. L., Dwivedi, S., Collins, B., Thurberg, B. L., Mattaliano, R. J., Nagaraju, K., and Plotz, P. H. (2003) Enzyme replacement therapy in the mouse model of Pompe disease. Mol. Genet. Metab. 80, 159-169
60. Raben, N., Fukuda, T., Gilbert, A. L., de Jong, D., Thurberg, B. L., Mattaliano, R. J., Meikle, P., Hopwood, J. J., Nagashima, K., Nagaraju, K., and Plotz, P. H. (2005) Replacing acid α-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers. Mol. Ther. 11, 48-56
61. Duplomb, L., Duvet, S., Picot, D., Jego, G., El Chehadeh-Djebbar, S., Marlem N., Gigot, N., Aral, B., Carmignac, V., Thevenon, J., Lopez, E., Rivière, J. B., Klein, A., Philippe, C., Droin, N., Blair, E., Girodon, F., Donadieu, J., Bellanné-Chantelot, C., Delva, L., Michalski, J. C., Solary, E., Faivre, L., Foulquier, F., and Thauvin-Robinet, C. (2014) Cohen syndrome is associated with major glycosylation defects. Hum. Mol. Genet. 23, 2391-2399
62. Shestakova, A., Zolov, S., and Lupashin, V. (2006) COG complex-mediated recycling of Golgi glycosyltransferases is essential for normal protein glycosylation. Traffic 7, 191-204
63. Foulquier, F., Amyere, M., Jaeken, J., Zeevaert, R., Schollen, E., Race, V., Bammens, R., Morelle, W., Rosnoblet, C., Legrand, D., Demaegd, D., Buist, N., Cheillan, D., Guffon, N., Morsomme, P., Annaert, W., Freeze, H. H., Van Schaftingen, E., Vikkula, M., and Matthijs, G. (2012) TMEM165 deficiency causes a congenital disorder of glycosylation. Am. J. Hum. Genet. 91, 15-26
64. Sparks, S. E., and Krasnewich, D. M. (2005) in GeneReviews® [Internet] (Pagon, R. A., Adam, M. P., Ardinger, H. H., et al., eds) Congenital Disorders of N-linked Glycosylation Pathway Overview, University of Washington, Seattle, http://www.ncbi.nlm.nih.gov/books/NBK1332
65. Wopereis, S., Grünewald, S., Morava, E., Penzien, J. M., Briones, P., García-Silva, M. T., Demacker, P. N., Huijben, K. M., and Wevers, R. A. (2003) Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis. Clin. Chem. 49, 1839-1845
66. Carchon, H. A., Chevigné, R., Falmagne, J. B., and Jaeken, J. (2004) Diagnosis of congenital disorders of glycosylation by capillary zone electrophoresis of serum transferrin. Clin. Chem. 50, 101-111
67. Freeze, H. H., and Schachter, H. (2009) Genetic disorders of glycosylation, in Essentials of Glycobiology (Varki, A., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., and Etzler, M. E., eds) 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, http://www.ncbi.nlm.nih.gov/books/NBK1939
68. Freeze, H. H., and Aebi, M. (2005) Altered glycan structures: the molecular basis of congenital disorders of glycosylation. Curr. Opin. Struct. Biol. 15, 490-498
69. Taylor, K. M., Meyers, E., Phipps, M., Kishnani, P. S., Cheng, S. H., Scheule, R. K., and Moreland, R. J. (2013) Dysregulation of multiple facets of glycogen metabolism in a murine model of Pompe disease. PLoS One 8, e56181
70. Poüs, C., Guibourdenche, J., Drechou, A., and Durand, G. (1994) Differential secretion of α1-acid glycoprotein occurs in the Golgi complex of isolated rat hepatocytes: evidence of partial retention in the Golgi. Eur. J. Biochem. 219, 1073-1079
71. Hayee, B., Antonopoulos, A., Murphy, E. J., Rahman, F. Z., Sewell, G., Smith, B. N., McCartney, S., Furman, M., Hall, G., Bloom, S. L., Haslam, S. M., Morris, H. R., Boztug, K., Klein, C., Winchester, B., Pick, E., Linch, D. C., Gale, R. E., Smith, A. M., Dell, A., and Segal, A. W. (2011) G6PC3 mutations are associated with a major defect of glycosylation: a novel mechanism for neutrophil dysfunction. Glycobiology 21, 914-924
72. Freeze, H. H., Chong, J. X., Bamshad, M. J., and Ng, B. G. (2014) Solving glycosylation disorders: fundamental approaches reveal complicated pathways. Am. J. Hum. Genet. 94, 161-175
73. Szumilo, T., Kaushal, G. P., and Elbein, A. D. (1987) Purification and properties of the glycoprotein processing N-acetylglucosaminyltransferase II from plants. Biochemistry 26, 5498-5505
74. Ikeda, Y., Koyota, S., Ihara, H., Yamaguchi, Y., Korekane, H., Tsuda, T., Sasai, K., and Taniguchi, N. (2000) Kinetic basis for the donor nucleotide-sugar specificity of β1,4-N-acetylglucosaminyltransferase III. J. Biochem. 128, 609-619
75. Sasai, K., Ikeda, Y., Fujii, T., Tsuda, T., and Taniguchi, N. (2002) UDP-GlcNAc concentration is an important factor in the biosynthesis of β1,6-branched oligosaccharides: regulation based on the kinetic properties of N-acetylglucosaminyltransferase V. Glycobiology 12, 119-127
76. Elices, M. J., and Goldstein, I. J. (1990) Initiation of poly-N-acetyllactosamine chain biosynthesis occurs preferentially on complex multiantennary asparagine-linked oligosaccharides. Carbohydr. Res. 203, 109-118
77. Akama, T. O., Nakagawa, H., Wong, N. K., Sutton-Smith, M., Dell, A., Morris, H. R., Nakayama, J., Nishimura, S., Pai, A., Moremen, K. W., Marth, J. D., and Fukuda, M. N. (2006) Essential and mutually compensatory roles of α-mannosidase II and α-mannosidase IIx in N-glycan processing in vivo in mice. Proc. Natl. Acad. Sci. U.S.A. 103, 8983-8988
78. Abdul Rahman, S., Bergström, E., Watson, C. J., Wilson, K. M., Ashford, D. A., Thomas, J. R., Ungar, D., and Thomas-Oates, J. E. (2014) Filter-aided N-glycan separation (FANGS): a convenient sample preparation method for mass spectrometric N-glycan profiling. J. Proteome Res. 13, 1167-1176
79. Wells, L. (2013) The O-mannosylation pathway: glycosyltransferases and proteins implicated in congenital muscular dystrophy. J. Biol. Chem. 288, 6930-6935
80. Kabaeva, Z., Meekhof, K. E., and Michele, D. E. (2011) Sarcolemma instability during mechanical activity in Largemyd cardiac myocytes with loss of dystroglycan extracellular matrix receptor function. Hum. Mol. Genet. 20, 3346-3355
81. Marquardt, T., and Denecke, J. (2003) Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies. Eur. J. Pediatr. 162, 359-379
82. Marengo, F. D., Wang, S. Y., Wang, B., and Langer, G. A. (1998) Dependence of cardiac cell Ca2+ permeability on sialic acid-containing sarcolemmal gangliosides. J. Mol. Cell. Cardiol. 30, 127-137
83. Post, J. A. (1992) Removal of sarcolemmal sialic acid residues results in a loss of sarcolemmal functioning and integrity. Am. J. Physiol. 263, H147-H152
84. Wilkins, B. J., and Molkentin, J. D. (2004) Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem. Biophys. Res. Commun. 322, 1178-1191
85. Montpetit, M. L., Stocker, P. J., Schwetz, T. A., Harper, J. M., Norring, S. A., Schaffer, L., North, S. J., Jang-Lee, J., Gilmartin, T., Head, S. R., Haslam, S. M., Dell, A., Marth, J. D., and Bennett, E. S. (2009) Regulated and aberrant glycosylation modulate cardiac electrical signaling. Proc. Natl. Acad. Sci. U.S.A. 106, 16517-16522
86. Fermini, B., and Nathan, R. D. (1991) Removal of sialic acid alters both T- and L-type calcium currents in cardiac myocytes. Am. J. Physiol. 260, H735-H743
87. Norring, S. A., Ednie, A. R., Schwetz, T. A., Du, D., Yang, H., and Bennett, E. S. (2013) Channel sialic acids limit hERG channel activity during the ventricular action potential. FASEB J. 27, 622-631
88. Ednie, A. R., Horton, K. K., Wu, J., and Bennett, E. S. (2013) Expression of the sialyltransferase, ST3Gal4, impacts cardiac voltage-gated sodium channel activity, refractory period, and ventricular conduction. J. Mol. Cell Cardiol. 59, 117-127